The evolving story of incretins ( <scp>GIP</scp> and <scp>GLP</scp> ‐1) in metabolic and cardiovascular disease: A pathophysiological update

A. Nauck, Michael; R. Quast, Daniel; Wefers, Jakob; Pfeiffer, Andreas

doi:10.1111/dom.14496

Public

The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update

Published in Diabetes Obesity and Metabolism • Jul 26, 2021

Authors:

Michael A. Nauck

Daniel R. Quast

Jakob Wefers

Abstract

Abstract The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion after their nutrient‐induced secretion from the gut. A functioning entero‐insular (gut‐endocrine pancreas) axis is ...

Subject

Incretin

Endocrinology

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!